Xilio Therapeutics Stock (NASDAQ: XLO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 94.000 / 1.185M |
Day Range | - - - |
52 Wk Range | 0.490 - 3.400 |
Market Cap | $40.234M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 0.17% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Xilio Therapeutics (NASDAQ: XLO) through any online brokerage.
Other companies in Xilio Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
The latest price target for Xilio Therapeutics (NASDAQ: XLO) was reported by Chardan Capital on Tuesday, May 30, 2023. The analyst firm set a price target for 7.00 expecting XLO to rise to within 12 months (a possible 542.20% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Xilio Therapeutics (NASDAQ: XLO) is $1.09 last updated April 23, 2024 at 7:44 PM EDT.
There are no upcoming dividends for Xilio Therapeutics.
Xilio Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Xilio Therapeutics.
Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.